BiotechTube

Methylphenidate

ApprovedWithdrawn
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Attention Deficit Hyperactivity Disorder

Conditions

Attention Deficit Hyperactivity Disorder

Trial Timeline

Apr 1, 2013 → Apr 1, 2015

NCT ID
NCT01764672

About Methylphenidate

Methylphenidate is a approved stage product being developed by Brain Biotech for Attention Deficit Hyperactivity Disorder. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01764672. Target conditions include Attention Deficit Hyperactivity Disorder.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01764672ApprovedWithdrawn

Competing Products

20 competing products in Attention Deficit Hyperactivity Disorder

See all competitors
ProductCompanyStageHype Score
atomoxetineEli LillyApproved
85
Atomoxetine + PlaceboEli LillyPhase 2/3
65
AtomoxetineEli LillyApproved
85
Atomoxetine HydrochlorideEli LillyApproved
85
AtomoxetineEli LillyPhase 3
77
AtomoxetineEli LillyApproved
85
Atomoxetine hydrochloride + PlaceboEli LillyApproved
85
CLONICEL (Clonidine HCl sustained release)ShionogiPhase 3
77
Donepezil hydrochloride + PlaceboEisaiPhase 3
77
LY2216684 + Methylphenidate + Placebo (tablet) + Placebo (capsule)Eli LillyPhase 2/3
65
Atomoxetine + PlaceboEli LillyApproved
85
AtomoxetineEli LillyApproved
85
AtomoxetineEli LillyPre-clinical
23
Atomoxetine HydrochlorideEli LillyApproved
85
Atomoxetine hydrochlorideEli LillyPhase 3
77
Atomoxetine Hydrochloride + PlaceboEli LillyApproved
85
atomoxetineEli LillyPhase 3
77
atomoxetine 0.5 mg/kg/day + placebo + atomoxetine 1.2 mg/kg/day + atomoxetine 1.2-1.4 mg/kg/dayEli LillyPhase 3
77
Atomoxetine HydrochlorideEli LillyApproved
85
Atomoxetine HydrochlorideEli LillyPhase 3
77

Other Products from Brain Biotech

FCYC+Conventional treatment + conventional treatmentApproved
77
Escitalopram + PlaceboApproved
77
Sinemet CR + Placebo oral capsuleApproved
77
MethylprednisoloneApproved
77
Paliperidone Palmitate Injection (PP1M)Approved
77